- In January 2025, the Lubrizol Corporation is set to present its medical-grade thermoplastic polyurethane (TPU) solutions at MD&M West 2025 in Anaheim, CA, from February 4 to 6. Lubrizol’s experts will highlight TPU applications in interventional vascular, ophthalmic, and drug delivery markets, reinforcing its role in advancing medical device innovation
- In November 2024, Wanhua Chemical unveiled polyurethane foam recycling technology at COP29, enabling 30% polyol recovery without degradation. Its bio-based TPU and HDI-type TPU enhance comfort in sports applications, while medical-grade TPU meets healthcare demands. These innovations reinforce sustainable materials' role in reducing carbon emissions across industries
- In November 2024, Lubrizol and Polyhose signed an MoU to expand medical tubing production in Chennai, increasing capacity five-fold. The facility will produce high-performance thermoplastic polyurethane (TPU) tubing for neurovascular and cardiovascular applications, supporting local manufacturing and global exports. Operations are set to begin in 2026
- In October 2024, BASF introduced Elastollan 1400, a new ether-based TPU series with excellent hydrolysis resistance and mechanical properties. It offers superior burst pressure, aging stability, and improved sustainability with a lower carbon footprint. Ideal for various industries, including transportation, footwear, and industrial manufacturing, the TPU is available for sampling after two years of research
- In September 2024, Covestro is building a new Thermoplastic Polyurethane (TPU) application development center in Guangzhou, China, set to open in 2025. The center will enhance customer proximity, foster innovation, and support industries such as electronics, footwear, and mobility. This expansion follows the construction of Covestro's largest TPU plant in nearby Zhuhai
